Kiyomi Mashima

10PUBLICATIONS
20CO-AUTHORS
Haematological tumoursMolecular targetsGene and molecular therapyEpigenetics (incl. genome methylation and epigenomics)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 23, 2025
Mutations and translocations associated with venetoclax resistance in chronic lymphocytic leukemia.

Kiyomi Mashima, Yanan Kuang, Stacey M Fernandes

|Mar 05, 2024
Fatty Acids Play a Critical Role in Mitochondrial Oxidative Phosphorylation in Effector T Cells in Graft-versus-Host Disease.

Hirofumi Nakano, Kazuya Sato, Junko Izawa

|Feb 05, 2024
Mutations Detected in Real World Clinical Sequencing during BTK Inhibitor Treatment in CLL.

Jennifer Brown, Kiyomi Mashima, Stacey Fernandes

|Jan 20, 2023
Relapsed and refractory multiple myeloma: A systematic review and network meta-analysis of the efficacy of novel therapies.

Daisuke Minakata, Shin-Ichiro Fujiwara, Daizo Yokoyama

|Oct 31, 2022
Rare Germline ATM Variants Influence the Development of Chronic Lymphocytic Leukemia.

Benjamin L Lampson, Aditi Gupta, Svitlana Tyekucheva

|Feb 16, 2022
Dimethyl fumarate ameliorates graft-versus-host disease by inhibiting T-cell metabolism and immune responses through a reactive oxygen species-dependent mechanism.

Kiyomi Mashima, Kazuya Sato, Takashi Ikeda

Pageof 2

Frequent Collaborators

3 joint publications

Yoshinobu Kanda

3 joint publications

Kazuya Sato

2 joint publications

Kazuo Muroi

2 joint publications

Kaoru Morita